MALAT1 and non-small cell lung carcinoma: The expression of MALAT1 is upregulated in Non Small Cell Lung Cancer (NSCLC) and ovarian cancer metastatic tumors [90,91], promotes aggressive phenotypes [91,92,93], and can be used as a prognostic biomarker in stage I NSCLC [90].